We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

129 hedge funds and large institutions have $332M invested in Aerie Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

299% more call options, than puts

Call options by funds: $842K | Put options by funds: $211K

7% less repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 41

6% less funds holding

Funds holding: 137 → 129 (-8)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

36% less capital invested

Capital invested by funds: $522M → $332M (-$190M)

Holders
129
Holders Change
-8
Holders Change %
-5.84%
% of All Funds
1.98%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
38
Reduced
41
Closed
35
Calls
$842K
Puts
$211K
Net Calls
+$631K
Net Calls Change
-$1.58M

Top Buyers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
+$24.9M
2
Morgan Stanley
Morgan Stanley
New York
+$19M
3
DM
Deerfield Management
New York
+$18M
4
Millennium Management
Millennium Management
New York
+$9.31M
5
CSS
Cubist Systematic Strategies
Connecticut
+$4.77M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$11.4M
2
William Blair Investment Management
William Blair Investment Management
Illinois
-$11.2M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$10.4M
4
ClearBridge Investments
ClearBridge Investments
New York
-$9.93M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
101
Virtu Financial
New York
$92K +$138K +13,155 New
AGM
102
Alpine Global Management
New York
$90K +$134K +12,831 New
TRCT
103
Tower Research Capital (TRC)
New York
$87K +$96.6K +9,230 +298%
ASRS
104
Arizona State Retirement System
Arizona
$85K -$607 -58 -0.5%
MLICM
105
Metropolitan Life Insurance Company (MetLife)
New York
$82.5K -$387 -37 -0.3%
Mirae Asset Global Investments
106
Mirae Asset Global Investments
South Korea
$75K +$2.52K +241 +2%
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
$63.1K +$14.7K +1,401 +18%
Public Employees Retirement Association of Colorado
108
Public Employees Retirement Association of Colorado
Colorado
$58K – – –
UBS Group
109
UBS Group
Switzerland
$48K +$38.1K +3,645 +113%
MA
110
Montag & Associates
Georgia
$44K -$14.6K -1,400 -18%
Macquarie Group
111
Macquarie Group
Australia
$39K – – –
DFCM
112
Dark Forest Capital Management
Puerto Rico
$38K +$43.2K +4,124 +326%
Osaic Holdings
113
Osaic Holdings
Arizona
$36K -$33.6K -3,213 -39%
Zurich Cantonal Bank
114
Zurich Cantonal Bank
Switzerland
$35K – – –
AIP
115
Ameritas Investment Partners
Nebraska
$22K – – –
ST
116
Smithfield Trust
Pennsylvania
$21K +$31.5K +3,010 New
Lazard Asset Management
117
Lazard Asset Management
New York
$21K +$31.9K +3,048 New
CG
118
Cutler Group
California
$18K – – –
Simplex Trading
119
Simplex Trading
Illinois
$17K +$18.5K +1,771 +234%
Canada Life
120
Canada Life
Manitoba, Canada
$13K – – –
US Bancorp
121
US Bancorp
Minnesota
$9K -$8.44K -807 -38%
Nisa Investment Advisors
122
Nisa Investment Advisors
Missouri
$5K -$82.5K -7,883 -92%
WAM
123
Wolverine Asset Management
Illinois
$4K +$6.55K +626 New
LJHT
124
Laurie J. Hall Trustee
$3K – – –
Group One Trading
125
Group One Trading
Illinois
$2K +$3.14K +300 New
3 4
5
6 7

AERI Hedge Fund Activity: Q4 2021 in Review

129 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2021, worth a combined $332M — down 36% from $522M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of AERI and 28 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 38 added.

The largest buyer was Jefferies Group, opening a new position worth an estimated $24.9M. The largest seller was PFM Health Sciences, cutting an estimated $11.4M.

  • 129 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2021, down from 137 in Q3 2021.
  • Funds reported $332M of Aerie Pharmaceuticals stock for Q4 2021, down 36% quarter-over-quarter.
  • 28 funds opened new Aerie Pharmaceuticals positions in Q4 2021 and 35 closed out, a net change of -7 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2021 was Jefferies Group, an estimated $24.9M added.
  • The largest Aerie Pharmaceuticals seller in Q4 2021 was PFM Health Sciences, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2021.